NCT07426484 2026-02-23Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic MalignancyDana-Farber Cancer InstitutePhase 4 Not yet recruiting80 enrolled
NCT07192471 2025-09-25A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin LymphomaKyowa Kirin Co., Ltd.Phase 1 Not yet recruiting72 enrolled